Cargando…

Editorial: Cellular Therapies in Cancer

Detalles Bibliográficos
Autores principales:	Rafei, Hind, Mehta, Rohtesh S., Rezvani, Katayoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890829/ https://www.ncbi.nlm.nih.gov/pubmed/31827476 http://dx.doi.org/10.3389/fimmu.2019.02788

Ejemplares similares

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Cord Blood as a Source of Natural Killer Cells
por: Mehta, Rohtesh S., et al.
Publicado: (2016)

Editorial: Cellular Therapies: Past, Present and Future
por: Dressel, Ralf, et al.
Publicado: (2018)

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
por: Rezvani, Katayoun, et al.
Publicado: (2015)

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease
por: Khoder, Ahmad, et al.
Publicado: (2018)

CAR‐NK cells: the next wave of cellular therapy for cancer
por: Daher, May, et al.
Publicado: (2021)

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation
por: Cao, Kai, et al.
Publicado: (2018)

Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future
por: Sanchez-Petitto, Gabriela, et al.
Publicado: (2023)

Editorial: Molecular and Cellular Effectors in the Resolution of Inflammation
por: Ariel, Amiram, et al.
Publicado: (2022)

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials
por: Mehta, Rohtesh S., et al.
Publicado: (2015)

Editorial: Producing, Sensing and Responding to Cellular Stress in Immunity
por: Paula-Neto, Heitor A., et al.
Publicado: (2019)

Editorial: Molecular and Cellular Pathways in NK Cell Development
por: Sitnicka, Ewa, et al.
Publicado: (2020)

Editorial: Global excellence in cellular immunology: Europe 2021
por: Uhrberg, Markus, et al.
Publicado: (2023)

Editorial: Recent Advances in Drosophila Cellular and Humoral Innate Immunity
por: Vesala, Laura, et al.
Publicado: (2020)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

Editorial: In vitro cellular technologies for advancing research in anamniote vertebrate immunology
por: Vo, Nguyen T. K., et al.
Publicado: (2023)

Microphysiological Systems for Studying Cellular Crosstalk During the Neutrophil Response to Infection
por: Richardson, Isaac M., et al.
Publicado: (2021)

Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies
por: Di Stasi, Antonio, et al.
Publicado: (2015)

Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse
por: Santiago, Virginia, et al.
Publicado: (2018)

Adoptive cell therapy: Living drugs against cancer
por: Laskowski, Tamara, et al.
Publicado: (2020)

Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis
por: Antonangeli, Fabrizio, et al.
Publicado: (2021)

Secretory co-factors in next-generation cellular therapies for cancer
por: Okuma, Atsushi, et al.
Publicado: (2022)

Editorial: Current Concepts of Cellular and Biological Drugs to Modulate Regulatory T Cell Activity in the Clinic
por: Jonuleit, Helmut, et al.
Publicado: (2016)

Jejunal Intussusception as an Unusual Cause of Abdominal Pain in an Adult
por: Mehta, Rohtesh S.
Publicado: (2009)

Editorial: Innovative 3D technologies in cancer immunity research and therapy
por: Gupta, Deepak, et al.
Publicado: (2023)

Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022
por: Martín-Antonio, Beatriz
Publicado: (2023)

Editorial: Advances in Pathogenesis and Therapies of Gout
por: Duan, Lihua, et al.
Publicado: (2022)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

Editorial: Innate immunity: platelets and their interaction with other cellular elements in host defense and disease pathogenesis
por: Kannan, Meganathan, et al.
Publicado: (2023)

Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
por: Lloyd, Angharad, et al.
Publicado: (2013)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Editorial: Roles of Fc Receptors in Disease and Therapy
por: Ganesan, Latha P., et al.
Publicado: (2020)

Editorial: Autoimmune Vasculitis - Advances in Pathogenesis and Therapies
por: Ooi, Joshua D., et al.
Publicado: (2021)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Editorial: Immunogenicity and toxicity of AAV gene therapy
por: Bradbury, Allison, et al.
Publicado: (2023)

Editorial: Sex differences in immunometabolism, prophylaxis and therapy
por: Fink, Ashley, et al.
Publicado: (2023)

Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
por: Wenger, Valentin, et al.
Publicado: (2023)

Editorial: Neutrophils in Cancer
por: Segal, Brahm H., et al.
Publicado: (2022)

Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer
por: Li, Xiaolin, et al.
Publicado: (2023)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
por: Slaney, Clare Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2cs5f7hra7i0ljsfprbousmdmt